BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 34735653)

  • 1. Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.
    Hleihel R; Akkouche A; Skayneh H; Hermine O; Bazarbachi A; El Hajj H
    Curr Oncol Rep; 2021 Nov; 23(12):141. PubMed ID: 34735653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
    Nasr R; Marçais A; Hermine O; Bazarbachi A
    Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Treatments of Adult T Cell Leukemia Lymphoma.
    El Hajj H; Tsukasaki K; Cheminant M; Bazarbachi A; Watanabe T; Hermine O
    Front Microbiol; 2020; 11():1062. PubMed ID: 32547515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis.
    Satake A; Konishi A; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Ito T; Ishii K; Nomura S
    Eur J Haematol; 2020 Dec; 105(6):704-711. PubMed ID: 32564395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the treatment of adult T-cell leukemia-lymphomas.
    Utsunomiya A; Choi I; Chihara D; Seto M
    Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
    Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the management of ATL].
    Ishitsuka K
    Rinsho Ketsueki; 2017; 58(6):676-682. PubMed ID: 28680001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
    Nosaka K; Matsuoka M
    Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for adult T-cell leukemia/lymphoma.
    Marçais A; Suarez F; Sibon D; Frenzel L; Hermine O; Bazarbachi A
    Curr Oncol Rep; 2013 Oct; 15(5):457-64. PubMed ID: 23943384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult T-cell leukemia-lymphoma.
    Tsukasaki K
    Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult T-Cell Leukemia-Lymphoma.
    Munakata W; Tobinai K
    Cancer Treat Res; 2019; 176():145-161. PubMed ID: 30596217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology and treatment of HTLV-1 associated T-cell lymphomas.
    Tsukasaki K; Tobinai K
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
    Kannagi M; Hasegawa A; Nagano Y; Iino T; Okamura J; Suehiro Y
    Cancer Sci; 2019 Mar; 110(3):849-857. PubMed ID: 30666755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].
    Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
    Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.
    Sakamoto H; Itonaga H; Sawayama Y; Furumoto T; Fujioka M; Chiwata M; Toriyama E; Kasai S; Nakashima J; Horai M; Kato T; Sato S; Ando K; Taguchi J; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Miyazaki Y
    Hematol Oncol; 2020 Apr; 38(2):162-170. PubMed ID: 31922287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.
    Yasunaga J; Matsuoka M
    Cancer Control; 2007 Apr; 14(2):133-40. PubMed ID: 17387298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
    Cook LB; Taylor GP
    Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
    Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
    J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.